The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk ( NVO) and Eli Lilly ( LLY) by introducing GLP-1 pills.

Boasted as being a “breakthrough capsule formula designed to boost GLP-1 hormone levels, reduce hunger and cravings and ...

"Weight loss medications are not one size fits all and patients should always discuss options with a trusted medical ...

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

Weight loss drugs have gained attention as a tool to help combat obesity, but understanding how they work, who they’re for, ...

The success of weight-loss injections has prompted pharmaceutical companies to produce a next-generation anti-obesity pill ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental ...

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

A PILL from the makers of Ozempic and Wegovy leads to faster and longer-lasting weight loss than the popular ‘skinny jabs’, a ...

Motley Rice LLC and other lead firms recently convened at the Philadelphia Federal Courthouse during a day-long science-based ...